STRESS MANAGEMENT EXPERT SYSTEM FOR CANCER PREVENTION
预防癌症的压力管理专家系统
基本信息
- 批准号:6377266
- 负责人:
- 金额:$ 31.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-09-01 至 2002-10-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Stage matched interventions for stress management that are interactive and individualized, and are delivered proactively to entire populations can have unprecedented impacts. Computer based expert systems linked to self-help manuals can be as effective as Counselors but at much lower cost and greater accessibility. Stress is an important cause of cancer and other chronic and acute diseases and is one of the most costly behaviors in terms of health care, job performance and disability. Fifty million Americans do not practice effective stress management. Existing programs are action- oriented and are designed for the 30% of populations who are prepared to take action. Stage matched programs can meet the needs of all; the 45% in the Precontemplation stage and the 25% in the Contemplation stage. Phase I of this Fast-Track research will demonstrate the feasibility of recruiting 70% of at-risk populations and the acceptability of the expert system interventions. Phase II will complete recruitment of 1200 participants randomly assigned to treatment or control and can demonstrate efficacy of these interventions over six months. Follow-up over 18 months can show increasing impact long after the intervention. Effective and cost-effective stress management systems can be broadly disseminated with consistent quality and user friendly acceptability. PROPOSED COMMERCIAL APPLICATIONS: Stress is one of the most costly conditions for individuals, employees and health care systems. Fifty million Americans do not practice effective stress management. Effective and cost effective expert systems that can treat stress on a population basis have outstanding commercial impact.
针对压力管理的阶段性配对干预措施是互动的、个性化的,并主动提供给整个人群,可能会产生前所未有的影响。与自助手册链接的基于计算机的专家系统可以与咨询人员一样有效,但成本低得多,而且更容易获得。压力是癌症和其他慢性和急性疾病的重要原因,也是医疗保健、工作表现和残疾方面代价最高的行为之一。5000万美国人没有进行有效的压力管理。现有方案是以行动为导向的,是为准备采取行动的30%的人口设计的。阶段匹配的方案可以满足所有人的需求;45%的人处于预想阶段,25%的人处于沉思阶段。这项快速通道研究的第一阶段将证明招募70%的高危人群的可行性和专家系统干预措施的可接受性。第二阶段将完成招募1200名随机分配到治疗或对照的参与者,并可在六个月内证明这些干预措施的有效性。超过18个月的随访显示,干预后很长一段时间内,影响会越来越大。有效和具有成本效益的压力管理系统可以广泛传播,具有一致的质量和用户友好的接受度。拟议的商业应用:压力是个人、员工和医疗保健系统代价最高的疾病之一。5000万美国人没有进行有效的压力管理。能够在人群基础上处理压力的有效和成本效益高的专家系统具有突出的商业影响。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kerry Evers其他文献
Kerry Evers的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kerry Evers', 18)}}的其他基金
Previvors Recharge: A Resilience Program for Cancer Previvors
癌症预防者恢复活力计划:癌症预防者恢复力计划
- 批准号:
10698965 - 财政年份:2023
- 资助金额:
$ 31.8万 - 项目类别:
Caring4Caregivers: A theory-driven mobile solution to promote self-care and well-being among caregivers of individuals with Alzheimer’s andrelated dementias
Caring4Caregivers:一种理论驱动的移动解决方案,旨在促进阿尔茨海默病和相关痴呆症患者的护理人员的自我护理和福祉
- 批准号:
10618164 - 财政年份:2022
- 资助金额:
$ 31.8万 - 项目类别:
Caring4Caregivers: A theory-driven mobile solution to promote self-care and well-being among caregivers of individuals with Alzheimer’s andrelated dementias
Caring4Caregivers:一种理论驱动的移动解决方案,旨在促进阿尔茨海默病和相关痴呆症患者的护理人员的自我护理和福祉
- 批准号:
10395174 - 财政年份:2022
- 资助金额:
$ 31.8万 - 项目类别:
Stage-Based Mobile Intervention for Substance Use Disorders in Primary Care: Implementation and Cluster-Randomized Trial
初级保健中药物滥用障碍的阶段性移动干预:实施和整群随机试验
- 批准号:
10405075 - 财政年份:2018
- 资助金额:
$ 31.8万 - 项目类别:
STRESS MANAGEMENT EXPERT SYSTEM FOR CANCER PREVENTION
预防癌症的压力管理专家系统
- 批准号:
6211051 - 财政年份:1999
- 资助金额:
$ 31.8万 - 项目类别:
STRESS MANAGEMENT EXPERT SYSTEM FOR CANCER PREVENTION
预防癌症的压力管理专家系统
- 批准号:
2869454 - 财政年份:1999
- 资助金额:
$ 31.8万 - 项目类别:
相似海外基金
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
癌症预防剂开发计划:早期临床研究
- 批准号:
10425188 - 财政年份:2021
- 资助金额:
$ 31.8万 - 项目类别:
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
癌症预防剂开发计划:早期临床研究
- 批准号:
10683047 - 财政年份:2021
- 资助金额:
$ 31.8万 - 项目类别:
CONTRACT TITLE - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
合同名称 - 癌症预防剂开发计划:早期临床研究
- 批准号:
10223848 - 财政年份:2020
- 资助金额:
$ 31.8万 - 项目类别:
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
癌症预防剂开发计划:早期临床研究
- 批准号:
10452466 - 财政年份:2019
- 资助金额:
$ 31.8万 - 项目类别:
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
癌症预防剂开发计划:早期临床研究
- 批准号:
10894578 - 财政年份:2019
- 资助金额:
$ 31.8万 - 项目类别:
OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
其他功能 - 癌症预防剂开发计划:早期临床研究
- 批准号:
10425187 - 财政年份:2019
- 资助金额:
$ 31.8万 - 项目类别:
CONTRACT TITLE - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
合同名称 - 癌症预防剂开发计划:早期临床研究
- 批准号:
10045660 - 财政年份:2019
- 资助金额:
$ 31.8万 - 项目类别:
OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
其他功能 - 癌症预防剂开发计划:早期临床研究
- 批准号:
10691840 - 财政年份:2019
- 资助金额:
$ 31.8万 - 项目类别:
CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
癌症预防剂开发计划:早期临床研究
- 批准号:
10045662 - 财政年份:2019
- 资助金额:
$ 31.8万 - 项目类别:
OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
其他功能 - 癌症预防剂开发计划:早期临床研究
- 批准号:
10045663 - 财政年份:2019
- 资助金额:
$ 31.8万 - 项目类别:














{{item.name}}会员




